Is a complete LENZ research report available?

No complete published report is available for LENZ Therapeutics, Inc. (LENZ) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · USD

$5.48

+0.43 (+8.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LENZ analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	171.8M
Revenue (ttm)	21M
Net income (ttm)	-109M
EPS (ttm)	-$3.66
Shares out	31.4M
Volume	1,429,504
Beta	1.62
Price target	$32.0	+483.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21M
Net income (ttm): -109M
EPS (ttm): -$3.66
Market cap: 171.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LENZ indicators

Market & fundamental data

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001815776
Company name	LENZ Therapeutics, Inc.
Country	United States
Country code	US
Cusip	52635N103
Employees	152
Employees Change	110%
Employees Change Percent	261.9
Enterprise value	$-85.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-06-25
Isin	US52635N1037
Last refreshed	2026-07-25
Market cap	$171.8M
Market cap category	Micro-Cap
Price	$5.48
Price currency	USD
Rev Per Employee	138,085.53x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2836
Symbol	LENZ
Website	https://www.lenz-tx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-63.44%
FCF yield	-50.89%
P/B ratio	0.7x
P/S ratio	8.19x
PS Forward	7.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-563.83%
EBITDA Margin	-562.1%
Gross margin	92.88%
Gross Profit	$19.5M
Net Income	$-109M
Net Income Growth Years	0%
Pretax Margin	-516.91%
Profit Per Employee	$-717,079
ROA	-31.22
ROCE	-47.96
ROE	-49.71
ROIC	-33.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-83.44%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.09
Assets	$272.5M
Cash	$258.4M
Current Assets	$268.4M
Current Liabilities	$25.8M
Debt	$673,000
Debt Equity	$0
Equity	$246.5M
Liabilities	$26M
Long Term Assets	$4.2M
Long Term Liabilities	$237,000
Net Cash	$257.7M
Net Cash By Market Cap	$150
Net Cash Growth	33.67%
Net Debt Equity	$-1.05
Tangible Book Value	$246.5M
Tangible Book Value Per Share	$7.86
WACC	13.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.4
Net Working Capital	$-15.4M
Quick ratio	10.11
Working Capital	$242.6M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.33%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-83.42%
200-day SMA	15.61
50-day SMA	6.33
50-day SMA vs 200-day SMA	50under200
All Time High	50.4
All Time High Change	-89.13%
All Time High Date	2025-10-02
All Time Low	4.68
All Time Low Change	17.09%
All Time Low Date	2026-07-16
ATR	0.42
Beta	1.62
Beta1y	2.5
Beta2y	1.42
Ch YTD	-65.75
High	5.5
High52	50.4
High52 Date	2025-10-02
High52ch	-89.13%
Low	5.03
Low52	4.68
Low52 Date	2026-07-16
Low52ch	17.09%
Ma50ch	-13.39%
Premarket Change Percent	-0.2
Premarket Price	$5.04
Premarket Volume	2,721
Price vs 200-day SMA	-64.89%
RSI	46.42
RSI Monthly	35.63
RSI Weekly	31.54
Sharpe ratio	-1.83x
Sortino ratio	-2.2
Total Return	-10.33%
Tr YTD	-65.75
Tr1m	-4.7%
Tr1w	5.79%
Tr3m	-40.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	5
Analyst Price Target Top	$32.2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.1
Earnings Revenue Estimate	2,470,000x
Earnings Revenue Estimate Growth	-50.6x
Operating Income	$-118.3M
Operating margin	-563.8
Price target	$32
Price Target Change	$484
Price Target Change Top	$488

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,877,659%
Float Percent	53.83%
Shares Insiders	2.65%
Shares Institutions	66.34%
Shares Out	31,354,394
Shares Qo Q	0.91%
Shares Yo Y	10.33%
Short Float	61.82%
Short Ratio	14.3
Short Shares	33.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-101.7M
Average Volume	1,112,477x
Bv Per Share	7.86
CAPEX	$-735,000
Ch1m	-4.7
Ch1w	5.79
Ch1y	-83.42
Ch3m	-40.11
Ch6m	-73.19
Change	8.51%
Change From Open	8.09
Close	5.05
Days Gap	0.4
Depreciation Amortization	362,000
Dollar Volume	7,833,681.9
Earnings Date	2026-07-29
Earnings Time	bmo
EBIT	$-118.3M
EBITDA	$-118M
EPS	$-3.66
F Score	1
FCF	$-87.4M
FCF EV Yield	101.8x
FCF Per Share	$-2.79
Financing CF	149,715,000
Fiscal Year End	December
Founded	2,019
Income Tax	$502,000
Investing CF	-61,396,000
Ipr	-67.76
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-24
Ma150	10.78
Ma150ch	-49.17%
Ma20	5.46
Ma20ch	0.4%
Net CF	1,616,000
Next Earnings Date	2026-08-07
Open	5.07
Optionable	Yes
Position In Range	95.74
Post Close	5.48
Postmarket Change Percent	-1.82
Postmarket Price	$5.38
Ppne	1,715,000
Pre Close	5.05
Price Date	2026-07-24
Ptbv Ratio	0.7
Relative Volume	1.28x
Revenue	20,989,000x
SBC By Revenue	68.18x
Share Based Comp	14,311,000
Tax By Revenue	2.39x
Tr6m	-73.19%
Us State	California
Volume	1,429,504
Z Score	16.26

LENZ Therapeutics, Inc. (LENZ)

Coverage state: Market snapshot only — no published research

Generate the first LENZ analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LENZ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LENZ indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LENZ

Frequently asked questions